Share Name Share Symbol Market Type Share ISIN Share Description
Inspiration Healthcare Group Plc LSE:IHC London Ordinary Share GB00BXDZL105 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.75% 132.50 131.00 134.00 133.50 130.50 133.00 31,493 12:06:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 37.0 3.1 5.1 26.0 90

Inspiration Healthcare Share Discussion Threads

Showing 801 to 824 of 825 messages
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
Just to let shareholders and prospective investors know that Inspiration Healthcare Group plc, ANGLE plc, Polarean Imaging plc, Diaceutics and IBT will be presenting at Mello Events’ Healthcare webinar on the 25th May at 5:30pm-9:30pm. The webinar will also include the latest insights and analysis from investment managers, research professionals, analysts and experienced investors. If you are a shareholder and you would like a ticket to the Healthcare event, please use the code SHVIP75 to receive 75% off your ticket. Https:// Additionally, on the 24th May, The Property Franchise Group PLC and Samarkand will be presenting at the MELLOMonday webinar event on 24th May at 6pm-9:30pm. There will also be special insights from Michael Taylor (@shiftingshares): Using technical analysis to find trades. There will be over 600 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions including the popular Mello BASH (Buy, Avoid, Sell or Hold). If you purchase a ticket to MELLOMonday, you will automatically get sent a link to the healthcare event! Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. Https://
Just to let you all know that the company are presenting at Mello Healthcare next week Https://
Crawley-based Inspiration Healthcare (IHC:120p), a fully integrated medical technology company with a strong focus on the high-growth neonatal intensive care market, has posted a major earnings beat on all levels.With the company's gross margin five percentage points higher than Cenkos Securities 43.6 per cent forecast, and annual revenues more than doubling to £37m, gross margin of £18m was £2.1m above analysts' estimates and operating profit of £4.3m was almost 50 per cent higher, too. Adjusted earnings per share (EPS) of 6.9p increased 90 per cent year on year, and net cash of £10.7m (15p a share) was almost double forecasts. Last summer's acquisition of SLE, a designer and maker of ventilators for neonatal intensive care, contributed £9.4m to revenue and there were £7.3m of one-off Covid-19 ventilators orders, too, but underlying revenue still increased 14 per cent. There is every reason to expect the positive trend to continue.In the past seven weeks, the company has received regulatory approval in Japan and China for its enhanced top-of-the-range SLE6000 neonatal ventilator that includes features such as enhanced High Frequency Oscillatory Ventilation (designed for use with critically ill infants) and the OxyGenie ┬« patented oxygen control algorithm (helps maintain infants at their targeted oxygen saturation levels). The higher-margin product has already received £650,000 of orders and chief executive Neil Campbell says that the two territories generated £2.8m-worth of orders with the old model, suggesting decent growth to come from the current base. SLE received a Queens Award for Enterprise this week in recognition of its work in developing an infant ventilator with the OxyGenie closed-loop software algorithm. It can only help boost sales.Sensibly, Inspiration is investing £2m in new facilities which will be operational this autumn to support additional growth capacity. The company is also making progress with its patented non-invasive, non-pharmaceutical respiratory device for apnoea of prematurity, aiming to sell it next year into a target market affecting 1.5m babies annually in the US, Europe and Japan.I suggested buying the shares, at 75p, last autumn (Alpha Research: 'Profit from a medical technology winner', 27 October 2020), and on an enterprise valuation of 12.5 times cash profit estimates, I see ample upside to my 150p target. Buy.
A very positive move into China. IHC have recieved approval and an immediate order from its distributor in China worth approximately £250,000for neonatal ventilator.Delivery during May 2021. Neil Campbell, Chief Executive Officer, commented "We are delighted that SLE has received approval for the SLE6000 in what is potentially one of our largest markets and also to announce that we have hit the ground running with a large order for immediate delivery.China represents a significant growth opportunity for the Group"
Profit taking after the tip has snowballed today
That explains the stream of buying
Simon Thompson commented on IHC yesterday in IC, concluding: 'Inspiration’s share price has kicked on 39 per cent since I highlighted the investment opportunity at 90p (‘Five small-caps with earnings upgrade tailwinds’, 2 February 2021), and is 67 per cent higher than when I initiated coverage, at 75p (Alpha Research: ‘Profit from a medical technology winner’, 27 October 2020). Trading on a trailing cash-adjusted price/earnings (PE) ratio of 20, Inspiration’s growth potential is still not yet fully priced in and I raise my target price to 150p. Buy.'
Looks ahead of schedule, Cenkos only had £500k (50 units) as a medium term target.
Good to see their recent acquisition SLE Ltd has received initial order of £400k from Japan for the new SLE6000 neonatal ventilator.
Naked Trader bought DYOR
cheshire man
Nice surprise to see the share price today - anyone know what happened here?
Anyone got any targets in mind for this one?
Pratt2 how many times has Robbie Burns aka the Naked Trader stated not to list his high risk share on these bulletin boards people have registered and paid him for these high risk tips.
Hi Pratt, where did you read this about NT buying? Not in diary? either way awesome rise and I bought in the mid 80's
thanks Pratt, I did check his website but it doesnt say he did and that was updated yesterday?
Bought by the naked trader yest. Target price 200
Hi - I found this article that was issued a week ago... HTTPS:// Inspiration Healthcare’s neonatal care drives hefty upgrades Operating profit estimates upgraded 18 per cent. SLE acquisition delivers increasing sales. Crawley-based Inspiration Healthcare (IHC:90p), a fully integrated medical technology company with a strong focus on the high growth neonatal intensive care market, is reaping the benefits of last summer’s £18m complementary acquisition of SLE, a designer and manufacturer of four types of ventilators for neonatal intensive care. SLE always looked like a good fit. That’s because Inspiration’s range of neonatal respiratory products support and assist the care of preterm infants by providing resuscitation, stabilisation and respiratory support. SLE’s sales have increased steadily since the deal completed in July, partly due to one-off Covid-19 orders but also reflects other factors such as cross-selling opportunities across the enlarged group (neonatal respiratory disposables and breathing circuits, for example). Inspiration’s directors note that the operational savings identified at the time of the acquisition are being achieved. The addition of SLE’s 30,000 sq. ft. facility in Croydon for the assembly of technically advanced capital equipment means that Inspiration now has 50,000 sq. ft. of manufacturing capacity. Inspiration is now less reliant on third party products, too. Moreover, with Inspiration’s annual revenue set to more than double to at least £36.5m (3 per cent ahead of forecasts) on a gross margin of around 43.6 per cent, then a higher proportion of incremental margin earned drops through to profit given Inspiration’s relatively fixed cost base. This explains why house broker Cenkos Securities has raised its operating profit estimate by 18 per cent to £2.86m, an 88 per cent year-on-year increase. On this basis, Cenkos expects adjusted EPS of 5.9p, up from 3.8p in the 2019/20 financial year, and closing net cash of £5.4m (8p a share). The SLE acquisition was one reason why I suggested buying the shares, at 75p (Alpha Research: ‘Profit from a medical technology winner’, 27 October 2020), noting that the enlarged business is well placed to benefit from organic growth trends in overseas markets while reaping synergy benefits across a wider customer base. Those dynamics are still at play. So, with the shares priced on a modest cash-adjusted forward PE ratio of 13.5, I maintain my 105p target price. Buy.
Does anyone know if this has been tipped? thanks Even at this level there is no stock to buy!
Great to see IHC smashing through £1. Cant see any particular reason why. Have I missed anything?
Ah - no wonder the price has risen! Must admit to being surprised at IHC reaching these levels. Well done to holders here. I sold too early but from memory I suspect the proceeds went into other stocks which have also risen since. So swings and roundabouts!
Recommended by Simon T in IC. Positive piece. Target 105p
Picked some of these up recently, really like the breakout after such a long time and they seem to be doing the business in a strong sector right now.
Results ahead of expectations and broker has increased FCs for FY22 too: hTTps://
Good to see GeneDrive's trial being successful for the Genedrive® MT-RNR1 ID Kit "Genedrive is now working with the study team to publish the data, due in early 2021, and with Inspiration Healthcare plc to plan the roll-out for commercial use. Full launch of the product is expected from June 2021, following the inclusion of feedback from the trial sites in the product configuration."
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210613 15:31:05